Novartis Lifts Annual Revenue and Earnings Outlook Amid Strong Drug Portfolio SOHOO Q2 2025 Earnings Preferred Dividend Coverage Remains Solid with EPS of 021 AppLovin Shares Surge 104 Following Bullish Analyst Call and Price Target Increase Erasca Inc Q1 2026 Earnings Significant EPS Miss Highlights Ongoing PreRevenue Challenges VITL Q1 2026 Earnings EPS Misses by Wide Margin as Costs Weigh TD SYNNEX SNX Q1 2026 Earnings Massive EPS Beat Surprises Markets MYRG Q1 2026 Earnings Significant EPS Beat Driven by Strong Execution Unicycive Therapeutics UNCY Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimate as Stock Moves Higher XOMAO Q1 2026 Earnings Preferred Shares Post Sharp EPS Miss as Royalty Income Disappoints STRL Q1 2026 Earnings Massive EPS Beat Driven by Strong Operational Execution